
### [NCIT:C4843](http://purl.obolibrary.org/obo/NCIT_C4843)
**Label:** Biliary Intraepithelial Neoplasia

**Subclasses:** [NCIT:C43606](http://purl.obolibrary.org/obo/NCIT_C43606) (Gallbladder Biliary Intraepithelial Neoplasia), [NCIT:C96942](http://purl.obolibrary.org/obo/NCIT_C96942) (Extrahepatic Bile Duct Biliary Intraepithelial Neoplasia), [NCIT:C67493](http://purl.obolibrary.org/obo/NCIT_C67493) (Biliary Intraepithelial Neoplasia-3), [NCIT:C96943](http://purl.obolibrary.org/obo/NCIT_C96943) (Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia), [NCIT:C96945](http://purl.obolibrary.org/obo/NCIT_C96945) (Bile Duct Biliary Intraepithelial Neoplasia), [NCIT:C67491](http://purl.obolibrary.org/obo/NCIT_C67491) (Biliary Intraepithelial Neoplasia-1), [NCIT:C67492](http://purl.obolibrary.org/obo/NCIT_C67492) (Biliary Intraepithelial Neoplasia-2), 

**Class expressions from DL-Learner:**

- Thing 53.30%
- [UBERON:0002423](http://purl.obolibrary.org/obo/UBERON_0002423) (hepatobiliary system) 52.94%
- [UBERON:0002294](http://purl.obolibrary.org/obo/UBERON_0002294) (biliary system) 52.94%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39624](http://purl.obolibrary.org/obo/NCIT_C39624) (Skin Plaque))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39622](http://purl.obolibrary.org/obo/NCIT_C39622) (Scaly Skin Eruption))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39620](http://purl.obolibrary.org/obo/NCIT_C39620) (Dermatopathic Lymphadenopathy))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39618](http://purl.obolibrary.org/obo/NCIT_C39618) (Subcutaneous Nodule))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39617](http://purl.obolibrary.org/obo/NCIT_C39617) (Subcutaneous Involvement))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39616](http://purl.obolibrary.org/obo/NCIT_C39616) (Karyorrhexis))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39615](http://purl.obolibrary.org/obo/NCIT_C39615) (Sinusoidal Infiltration))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39609](http://purl.obolibrary.org/obo/NCIT_C39609) (Activated Natural Killer Cell))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39608](http://purl.obolibrary.org/obo/NCIT_C39608) (Coagulative Necrosis))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39602](http://purl.obolibrary.org/obo/NCIT_C39602) (Pleomorphic Medium-Sized to Large T-Lymphocyte))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39600](http://purl.obolibrary.org/obo/NCIT_C39600) (Neoplastic Medium-Sized T-Lymphocyte))) 38.30%


